Vidarabine phosphate

Vidarabine phosphate (Ara-AMP), an antiviral agent, inhibits chronic HBV infection[1][2]. Vidarabine phosphate also against herpes simplex and varicella zoster viruses[3].

Product Specifications

CAS Number

[29984-33-6]

Product Name Alternative

Ara-AMP; ara-A 5'-monophosphate

UNSPSC

12352005

Hazard Statement

H315-H317-H319-H335-H360

Target

Antibiotic; HBV

Type

Reference compound

Related Pathways

Anti-infection

Applications

COVID-19-anti-virus

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/vidarabine-phosphate.html

Purity

98.74

Solubility

DMSO : 16.67 mg/mL (ultrasonic; warming; heat to 60°C) |H2O : 4.9 mg/mL (ultrasonic; warming; adjust pH to 7 with NaOH; heat to 60°C)

Smiles

NC1=C(N=CN2[C@H]3[C@@H](O)[C@H](O)[C@@H](COP(O)(O)=O)O3)C2=NC=N1

Molecular Formula

C10H14N5O7P

Molecular Weight

347.22

Precautions

P261-P264-P271-P272-P280-P302+P352-P304+P340-P362+P364-P405-P501

References & Citations

[1]A W Gough, et al. Comparison of the neonatal toxicity of two antiviral agents: vidarabine phosphate and cytarabine. Toxicol Appl Pharmacol. 1982 Oct;66 (1) :143-52. |[2]C I Smith, et al. Vidarabine monophosphate and human leukocyte interferon in chronic hepatitis B infection. JAMA. 1982 Apr 23;247 (16) :2261-5.|[3]D Kinchington. Recent advances in antiviral therapy. J Clin Pathol. 1999 Feb;52 (2) :89-94.